ライフサイエンスコーパス: exertional

1 ment and determine optimal time to return to exertional activities (eg, school, sports) is lacking.

2 .e., quinapril) prevents transient ischemia (exertional and spontaneous) in patients with coronary ar

3 was greater in stable (48.5%) and crescendo exertional angina (48.8%) than in rest angina (30.4%).

4 te myocardial infarction (n = 916) or stable exertional angina (n = 468).

5 alpha-actin and Lp(a) areas in the crescendo exertional angina (r = 0.62, p < 0.01).

6 y patients (mean age, 65.2+/-7.6 years) with exertional angina and coronary artery disease underwent

7 heart disease (IHD), myocardial ischemia and exertional angina are caused by obstructive atherosclero

8 either acute myocardial infarction or stable exertional angina between October 2001 and December 2003

9 -4.3 years) with a positive exercise ECG and exertional angina completed the protocol.

10 enter study, 41 men with reproducible stable exertional angina due to ischemic CAD received vardenafi

11 Severe aortic stenosis (AS) can manifest as exertional angina even in the presence of unobstructed c

12 arctions and 419 adults with incident stable exertional angina who had baseline eGFRs </=130 ml/min/1

13 tic, but this anomaly may be associated with exertional angina, acute coronary syndromes, cardiac arr

14 Compared with patients with incident stable exertional angina, patients with incident acute myocardi

15 A total of 178 patients with stable exertional angina, unsuitable for standard revasculariza

16 7%; P < 0.001) than patients presenting with exertional angina.

17 relatively stable coronary disease, such as exertional angina.

18 nts (50% men, mean age 66 +/- 10 years) with exertional anginal symptoms undergoing diagnostic angiog

19 o cardiac hemodynamics and determine whether exertional arterial stiffening can be mitigated by inorg

20 Exertional breathlessness, the principal symptom of HF,

21 IC was defined as the presence of exertional calf discomfort that was relieved with rest.

22 le for heart-arterial coupling in modulating exertional capacity in the elderly, suggesting a potenti

23 The SAQ scores for exertional capacity, anginal stability and frequency, tr

24 a 55 year old female who presented with non-exertional chest pain in the setting of an emotional str

25 In middle-aged men, exertional chest pain is a strong indicator of major cor

26 All patients with an episode of unstable exertional chest pain or chest pain at rest presumed to

27 in, nonexertional chest pain, or angina (Q) (exertional chest pain) on each occasion.

28 % of the screening forms included history of exertional chest pain, dyspnea, or fatigue; familial hea

29 d benign, though it has been associated with exertional chest pain, which may mimic acute coronary sy

30 oronary syndrome in patients presenting with exertional chest pain.

31 Rarely, an exertional compartment syndrome may become acute.

32 Patients with atypical exertional complaints require careful clinical and physi

33 Susceptibility to exertional cramps and rhabdomyolysis in myophosphorylase

34 plaque occurred in 18 (72%) of 25 men in the exertional-death group and 47 (41%) of 116 men in the re

35 aques in the coronary arteries of men in the exertional-death group was 1.6 (1.5) and in the at-rest

36 minant families with epilepsy and paroxysmal exertional dyskinesia (PED).

37 Most commonly reported symptoms were exertional dyspnea (78%) and fatigue (73%).

38 I] = 0.9-6.6%), a 1.6-fold increased odds of exertional dyspnea (95% CI = 1.3-1.9), a 1.5-fold increa

39 ient selection, including drug treatment for exertional dyspnea (beta-blockers, verapamil, disopyrami

40 The most common clinical presentation was exertional dyspnea (n=17; 65%), whereas 8 (31%) patients

41 rial, 150 subjects (age 67 +/- 9 years) with exertional dyspnea (New York Heart Association functiona

42 previously healthy soldiers with unexplained exertional dyspnea and diminished exercise tolerance aft

43 t children with asthma may falsely attribute exertional dyspnea and esophageal reflux to asthma, lead

44 ] age 70 +/- 12 years; 21 women, 9 men) with exertional dyspnea and negative exercise test results, a

45 s with moderate to severe heart failure that exertional dyspnea can be alleviated by improving muscle

46 pacemakers were implanted in 9 patients with exertional dyspnea caused by HHCO.

47 Exertional dyspnea disproportionate to pulmonary functio

48 Exertional dyspnea is a frequent limiting symptom in pat

49 Amelioration of exertional dyspnea is achieved by other mechanisms, such

50 After heart transplantation, exertional dyspnea is markedly diminished.

51 Exertional dyspnea or chest pain, prior limitation from

52 with heart failure are frequently limited by exertional dyspnea that may be due to the increased work

53 HF symptoms, especially exertional dyspnea, are common in ARVC/D; yet, classic l

54 Exertional dyspnea, chest pain, palpitations, and ankle

55 ars of age) with stage C heart failure (HF) (exertional dyspnea, New York Heart Association functiona

56 She has symptoms of fatigue, achiness, and exertional dyspnea.

57 of intermittent chest pain, palpitations and exertional dyspnoea.

58 ferent cardiovascular diseases, referred for exertional dyspnoea.

59 on fraction >50%, diastolic dysfunction, and exertional E/e' >13), excluding those with ischemic hear

60 improvements in peak oxygen uptake (VO2) and exertional E/e' ratio, and secondary outcomes were impro

61 Exertional echocardiography may indicate patients with i

62 All patients demonstrated a significant exertional effort as demonstrated with the mean peak exe

63 r daily activities in addition to supervised exertional exercises.

64 of pain, fatigue, cognitive dysfunction and exertional exhaustion.

65 pulmonary exercise testing and evaluation of exertional fatigue and dyspnea over a period of one to f

66 d regurgitation (TR) frequently present with exertional fatigue and dyspnea, but the hemodynamic basi

67 woman with recurrent lung cancer and severe exertional fatigue and dyspnea, illustrate how dyspneic

68 literation (HHCO) can result in debilitating exertional fatigue and dyspnea.

69 scle glycogen depletion results in increased exertional fatigue and reduced endurance.

70 ly exercising skeletal muscle contributes to exertional fatigue in HF.

71 ts with ESRD, raising the concern for severe exertional hyperkalemia.

72 0.34, p = 0.04) and change with treatment in exertional increase in the ratio of peak early diastolic

73 hemoglobin AS (HbAS) and who were subject to exertional-injury precautions.

74 n several components may interact to promote exertional intolerance in HFpEF.

75 thesis of a peripheral origin of symptoms of exertional intolerance in this syndrome is confirmed as

76 METHODS AND Among 65 patients with exertional intolerance undergoing upright invasive exerc

77 Exercise capacity and symptoms of exertional intolerance were correlated with abnormalitie

78 was associated with worse functional class, exertional intolerance, and increased mortality in PAH,

79 iopulmonary exercise testing for unexplained exertional intolerance.

80 oup without exertional leg pain/inactive (no exertional leg pain in individual who walks </=6 blocks

81 The differential diagnosis of exertional leg pain includes stress fractures, stress re

82 Although exertional leg pain is a hallmark of peripheral arterial

83 atypical exertional leg pain/carry on group (exertional leg pain other than IC associated with walkin

84 the atypical exertional leg pain/stop group (exertional leg pain other than IC that causes one to sto

85 No category of exertional leg pain was sufficiently sensitive or specif

86 ptomatic (participants who never experienced exertional leg pain, even during the 6-minute walk; n=72

87 Among participants without exertional leg pain, lower ABI levels were associated wi

88 isk variables were independent correlates of exertional leg pain.

89 arization were all significant correlates of exertional leg pain.

90 an Diego Claudication Questionnaire assessed exertional leg pain.

91 xty-three percent of PAD participants had no exertional leg pain.

92 compared with IC, participants with atypical exertional leg pain/carry on achieved a greater distance

93 The atypical exertional leg pain/carry on group (exertional leg pain

94 The group without exertional leg pain/inactive (no exertional leg pain in

95 through leg pain [n = 41]) and the atypical exertional leg pain/stop group (exertional leg pain othe

96 s, 30% to 60% of patients with PAD report no exertional leg symptoms and approximately 45% to 50% rep

97 Persons with PAD who never experience exertional leg symptoms have poorer functional performan

98 ng in those who are asymptomatic or who have exertional leg symptoms other than claudication.

99 symptoms and approximately 45% to 50% report exertional leg symptoms that are not consistent with cla

100 ribe 28 patients with unexplained dyspnea or exertional limitation secondary to biopsy-proven mitocho

101 therapeutic target for aged individuals with exertional limitations.

102 es and patellofemoral pain syndrome; chronic exertional lower-leg compartment syndrome, ankle sprains

103 We sought to confirm ACE genotype-associated exertional LV growth and to clarify the role of the AT(1

104 fluid indicated distinct mechanisms for post-exertional malaise in CFS and START and STOPP phenotypes

105 Post-exertional malaise suggests exercise alters central nerv

106 IONALE: An increased ventilatory response to exertional metabolic demand (high [Formula: see text]e/[

107 ycogen storage disease in humans that causes exertional myopathy and hemolysis.

108 somal recessive disorder characterized by an exertional myopathy and hemolytic syndrome.

109 The reduced exertional obstruction may account for the better functi

110 Because symptoms of HFpEF are typically exertional, optimization of diastolic filling time by co

111 issections are preceded by a specific severe exertional or emotional event.

112 than unstable angina patients with crescendo exertional pain (n = 18): 71.1% versus 52.4% (p < 0.001)

113 nse in this group was associated with higher exertional PcO2.

114 nant of aerobic capacity among patients with exertional pulmonary venous hypertension (ePVH).

115 with a significantly higher adjusted risk of exertional rhabdomyolysis (hazard ratio, 1.54; 95% CI, 1

116 -hazards models to test whether the risks of exertional rhabdomyolysis and death varied according to

117 that sickle cell trait elevates the risks of exertional rhabdomyolysis and death.

118 omes, controlling for known risk factors for exertional rhabdomyolysis, in a large population of acti

119 sociated with a significantly higher risk of exertional rhabdomyolysis.

120 ders by stress, the effect of psychologic or exertional stress on human skin has not been well studie

121 ow and independent determinants of disabling exertional symptoms and cardiovascular mortality.

122 However, exertional symptoms frequently underestimate the severit

123 vestigate the relationship over time between exertional symptoms in heart failure and functional capa

124 Most clinicians rely on exertional symptoms rather than on exercise testing to a

125 Exertional symptoms reported by patients with heart fail

126 tricular tachycardia [6], near-drowning [2], exertional syncope [1], symptoms on therapy [2], LQT3 [1

127 rocedure, exercise capacity was improved and exertional syncope abolished.

128 ded cardiac ryanodine receptor in cases with exertional syncope and normal corrected QT interval (QTc

129 disease is known or suspected or those with exertional syncope are at higher risk for adverse outcom

130 Angina, exertional syncope, and heart failure are key symptoms i

131 These were two of only six patients who had exertional syncope.

132 The chronic or exertional type most commonly involves the lower extremi

133 etes with symptoms of syncope, especially if exertional, warrant a complete evaluation.